Please try another search
Prescient Therapeutics Limited, a clinical stage oncology company, develops novel drugs for the treatment of various cancers in Australia. Its lead drug candidate is PTX-200, which is in Phase 2a clinical trial for HER2-negative breast cancer, Phase IB/2 clinical trial in relapsed and refractory AML, and Phase 1b in recurrent or persistent platinum-resistant ovarian cancer; and PTX-100, a RhoA inhibitor, for hematological and solid malignancies that focuses on cancers with Ras and RhoA mutations. It has a strategic collaboration with The University of Texas MD Anderson Cancer Center to develop blood cancer binder for OmniCAR. The company was formerly known as Virax Holdings Limited and changed its name to Prescient Therapeutics Limited in December 2014. The company was incorporated in 1986 and is based in Melbourne, Australia.
Name | Age | Since | Title |
---|---|---|---|
Steven B. Engle | 66 | 2014 | Independent Non-Executive Chairman |
Yatomi-Clarke Steven Lee | - | 2014 | MD, CEO & Director |
Rodney Daniel Sinclair | - | 2011 | Chairman of Clinical Advisory Board |
Allen Ebens | - | 2020 | Non-Executive Director |
Phillip Darcy | - | 2020 | Member of Scientific Advisory Board |
James A. Campbell | - | 2014 | Independent Non-Executive Director |
Andrew Tsourkas | - | 2021 | Member of Scientific Advisory Board |
Marco L. Davila | - | 2021 | Member of Scientific Advisory Board |
Ellen Gwen Feigal | 69 | 2023 | Independent & Non- Executive Director |
Joshua Douglas | - | 2014 | Member of Scientific Advisory Board |
Thomas Prebet | - | 2016 | Member of Scientific Advisory Board |
Reinhard Dummer | - | 2011 | Member of Clinical Advisory Board |
Jeffrey Lancet | - | 2015 | Member of Scientific Advisory Board |
Donald M. O’Rourke | - | 2021 | Member of Scientific Advisory Board |
Farhad Ravandi | - | 2015 | Member of Scientific Advisory Board |
H. Miles Prince | - | 2020 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review